VITRUVIAS THERAPEUTICS INC recalls Thyroid Tablets
- Recalling company
- VITRUVIAS THERAPEUTICS INC
- Product
- Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
- Reason
- Superpotent Drug
- Classification
- Class I – a reasonable probability that use will cause serious adverse health consequences or death
- Recall date
- Aug 21, 2026
- Reported
- Sep 23, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- 1955 bottles
- Lot / codes
- Lot # 504950, Exp Date: 09/30/2026.
- Company location
- Auburn, AL
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0866-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0866-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.